Breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and Alzheimer's patients, according to two new studies from researchers at the Case Western Reserve ...
May 23, 2022
0
89
Adults aged 45 to 64 experienced a nearly doubled rate of esophageal cancer and a 50 percent increase in the precancerous condition Barrett's esophagus between 2012 and 2019, according to a database analysis of roughly five ...
May 13, 2022
0
100
April is Sexually Transmitted Infections Awareness Month. About 70% of cancers in the oropharynx, which includes the tonsils, soft palate and base of the tongue, are linked to the HPV virus, according to the Centers for Disease ...
Apr 26, 2022
0
2
The most common head and neck cancer—oral squamous cell carcinoma—often starts off, as many other cancers do, quite innocently. Perhaps as a little white patch in the mouth or a small red bump on the gums. Easy to ignore, ...
Apr 26, 2022
0
19
A randomized controlled trial of 2,275 women in Kenya showed that a single dose of the human papillomavirus (HPV) vaccine was highly effective. The current standard for women is a three-dose regimen.
Apr 11, 2022
0
5
Results from early-stage clinical trials show two drugs that target the DNA damage response (DDR) pathway in cancers—ATR inhibitor elimusertib and PARP inhibitor AZD5305—are safe and clinically beneficial in treating ...
Apr 11, 2022
0
4
Columbia Engineering researchers report that they have developed a "cloaking" system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer ...
Mar 17, 2022
0
77
Researchers are set to test a non-invasive treatment for inoperable early-stage liver cancer, with a new clinical trial to commence this year across Australia.
Feb 24, 2022
0
3
In men undergoing active surveillance as an alternative to immediate treatment for prostate cancer, a supervised exercise program can reduce anxiety and fear of cancer progression, reports a study in The Journal of Urology.
Feb 18, 2022
0
4
(HealthDay)—A new lung cancer drug that has only been tested in China was soundly rejected by an advisory panel to the U.S. Food and Drug Administration on Thursday.
Feb 11, 2022
0
4
